Breakthrough Device Designation

The Breakthrough Devices Program is the FDA's expedited review pathway for medical devices that provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating conditions. Designated devices receive priority review, more interactive FDA engagement, and senior-management attention throughout the development process.

For digital health, software-as-medical-device, and novel diagnostic categories, Breakthrough Device Designation is among the highest-credibility regulatory signals a company can earn. Designated products appear in FDA press releases, are listed in the FDA Breakthrough Devices Program tracker, and earn durable Citation Share inside AI engines on category-defining and innovation queries — a structural retrieval lever for emerging healthtech vendors.

See: The Healthcare Pillar.